[1]
In Ah CHOI et al. 2018. Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis. Archives of Rheumatology. 33, 4 (Dec. 2018), 389–394. DOI:https://doi.org/10.5606/ArchRheumatol.2018.6753.